Daiichi Sankyo Pink Sheet Top Management
Daiichi Sankyo ownership has shifted over recent filings as shown below. About 21.0% of Daiichi Sankyo's shares are held by institutional investors. The split between insider and institutional ownership shapes governance dynamics and voting outcomes.
| Hiroyuki Okuzawa President Executive Officer and Presidentident of ASCA Company |
Daiichi Sankyo |
Management Team Effectiveness
DSNKY has return on total asset (ROA) of 2.09% indicating positive asset-level profitability for it. This is below the sector average. Daiichi Sankyo also reports a return on equity (ROE) of 4.32%, indicating positive equity-level profitability for it.Outstanding Bonds
Outstanding bonds linked to Daiichi Sankyo Co can tell investors a great deal about how the company finances itself beyond common equity markets. Longer-dated obligations can improve financing stability, but they also leave investors more exposed if the underlying business weakens before the debt matures.
| MBGGR 245 02 MAR 31 Corp BondUS233851ED24 | View | |
| MBGGR 31 15 AUG 29 Corp BondUS233851DW14 | View | |
| MBGGR 345 06 JAN 27 Corp BondUS233851CU66 | View | |
| MBGGR 43 22 FEB 29 Corp BondUS233851DT84 | View | |
| MBGGR 375 22 FEB 28 Corp BondUS233851DF80 | View | |
| DTRGR 365 07 APR 27 Corp BondUS233853AM25 | View | |
| DTRGR 25 14 DEC 31 Corp BondUS233853AH30 | View | |
| DTRGR 2375 14 DEC 28 Corp BondUS233853AG56 | View |
Holders Distribution
Institutional investors in Daiichi Sankyo Co typically operate with more research capacity, technology, and trading scale than retail holders, which is why their activity can materially affect price behavior. One practical risk is that institutions can own millions of shares, so concentrated selling can pressure the pink sheet quickly once sentiment changes.
Workforce Comparison
Daiichi Sankyo Co ranks first in number of employees among leading competitors. The total workforce of Drug Manufacturers—General industry is currently estimated at about 192,092. Daiichi Sankyo holds roughly 16,458 in number of employees claiming about 9% of equities under Drug Manufacturers—General sector.
DSNKY has Profit Margin (PM) of 5.0%. Similarly, it shows Operating Margin (OM) of 6.0%. Notable Stakeholders
A Daiichi Sankyo stakeholder is any individual or group with an interest in the outcome of the business, which is why stakeholder analysis can reveal who may influence strategy and oversight. The practical value is in seeing where interests align, where they conflict, and how that tension could influence execution.
| Hiroyuki Okuzawa | Executive Officer and Presidentident of ASCA Company | Profile | |
| Masahiko Ohtsuki | Executive Officer, Senior Director of Research in Main Research & Development Unit | Profile | |
| Junichi Onuma | VP Department | Profile | |
| Hideyuki Haruyama | Co Adviser | Profile | |
| Akio Sakurai | Corp Unit | Profile | |
| Yoshinori Kaneshima | Corp Unit | Profile | |
| Kentaro Asakura | VP Department | Profile | |
| Sunao DVM | Group Pres | Profile | |
| Naoto Tsukaguchi | Corp Counsel | Profile | |
| Takashi Matsumoto | Co HR | Profile | |
| Marielle MD | Global Devel | Profile |
Management Information & Data Sources
Daiichi Sankyo is a large-cap company in Cash Cows. Management effectiveness is reflected in operating results, capital allocation choices, and margin durability. Capital allocation discipline - buybacks, dividends, M&A, and capex - defines management quality over time. Daiichi Sankyo employs 16,458 people.
Daiichi Sankyo Co metrics are compiled from periodic company reporting and market reference feeds and normalized before display. Insider and management fields are mapped from published filings and company disclosures.
Editorial review and methodology oversight provided by: Vlad Skutelnik, Macroaxis Contributor
Workforce Efficiency and Productivity
Workforce metrics tied to Daiichi Sankyo Co offer a useful way to test whether headcount and economic output are moving in a productive direction. A disciplined workforce review can reveal whether execution quality is improving beneath the top-line numbers.
Daiichi Sankyo Manpower Efficiency
Return on Daiichi Sankyo Manpower
| Revenue Per Employee | 63.5M | |
| Revenue Per Executive | 95B | |
| Net Income Per Employee | 4.1M | |
| Net Income Per Executive | 6.1B | |
| Working Capital Per Employee | 49M | |
| Working Capital Per Executive | 73.3B |
Daiichi Sankyo has a market cap of 60.9 billion, an operating margin of 6.46% (TTM), current ratio of 3.36. Together, these metrics capture both earnings power and balance-sheet resilience. Broader economic conditions can influence Daiichi Sankyo Co's company valuation - related indicators include signals in employment.With Daiichi Sankyo showing P/E 92.74 and ROE 4.32%, this analysis gains depth when combined with the diversification and construction tools below. That valuation within Healthcare invites comparison with Drug Manufacturers—General peers using the tools below to judge whether the multiple is justified. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Related Tools for Daiichi Sankyo Pink Sheet
Comprehensive review of Daiichi Sankyo blends technical signals with balance-sheet trends.
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instrumentsETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investmentsFinancial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgetsStocks DirectoryFind actively traded stocks across global marketsRisk-Return AnalysisView associations between returns expected from investment and the risk you assumeBollinger BandsUse Bollinger Bands indicator to analyze target price for a given investing horizonEquity ForecastingUse basic forecasting models to generate price predictions and determine price momentum